{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:45:48Z","timestamp":1762508748666,"version":"3.44.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T00:00:00Z","timestamp":1646611200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.radonc.2022.02.036","type":"journal-article","created":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T10:58:33Z","timestamp":1646477913000},"page":"95-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Cost-effectiveness of prophylactic cranial irradiation in stage III non-small cell lung cancer"],"prefix":"10.1016","volume":"170","author":[{"given":"Willem J.A.","family":"Witlox","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bram L.T.","family":"Ramaekers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Lacas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecile","family":"Le Pechoux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si-Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Redman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"van der Noort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Guckenberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harm","family":"van Tinteren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lizza E.L.","family":"Hendriks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry J.M.","family":"Groen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela A.","family":"Joore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk K.M.","family":"De Ruysscher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2022.02.036_b0005","unstructured":"International Agency for Research on Cancer. Global Cancer Observatory. https:\/\/gco.iarc.fr\/today\/data\/factsheets\/populations\/900-world-fact-sheets.pdf. Accessed March 17, 2021."},{"key":"10.1016\/j.radonc.2022.02.036_b0010","unstructured":"American Cancer Society. Key Statistics for Lung Cancer. https:\/\/www.cancer.org\/cancer\/lung-cancer\/about\/key-statistics.html#references. Accessed March 17, 2021."},{"key":"10.1016\/j.radonc.2022.02.036_b0015","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.annonc.2021.08.1994","article-title":"Early and locally advanced non-small-cell lung cancer: an update of the ESMO Clinical Practice Guidelines focusing on diagnosis, staging, systemic and local therapy","volume":"32","author":"Remon","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2022.02.036_b0020","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/annonc\/mdv187","article-title":"2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer","volume":"26","author":"Eberhardt","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2022.02.036_b0025","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3389\/fonc.2018.00154","article-title":"Stereotactic radiosurgery in the management of patients with brain metastases of non-small cell lung cancer: indications, decision tools and future directions","volume":"8","author":"Hartgerink","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2022.02.036_b0030","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1200\/JCO.19.01162","article-title":"Long-Term Results of NRG Oncology RTOG 0617: standard-versus high-dose chemoradiotherapy with or without cetuximab for unresectable stage III non-small-cell lung cancer","volume":"38","author":"Bradley","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2022.02.036_b0035","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.radonc.2019.10.016","article-title":"Health-related quality of life after prophylactic cranial irradiation for stage III non-small cell lung cancer patients: Results from the NVALT-11\/DLCRG-02 phase III study","volume":"144","author":"Witlox","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.02.036_b0040","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.radonc.2021.02.002","article-title":"Individual patient data meta-analysis of prophylactic cranial irradiation in locally advanced non-small cell lung cancer","volume":"158","author":"Witlox","year":"2021","journal-title":"Radiother Oncol"},{"year":"2006","series-title":"Decision modelling for health economic evaluation","author":"Briggs","key":"10.1016\/j.radonc.2022.02.036_b0045"},{"key":"10.1016\/j.radonc.2022.02.036_b0050","first-page":"229","article-title":"A randomized trial of chemotherapy and radiotherapy for stage III non-small cell lung cancer","volume":"1","author":"Miller","year":"1998","journal-title":"Cancer Ther"},{"key":"10.1016\/j.radonc.2022.02.036_b0055","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/jamaoncol.2018.7220","article-title":"Prophylactic cranial irradiation vs observation in patients with locally advanced non-small cell lung cancer: A long-term update of the NRG oncology\/RTOG 0214 phase 3 randomized clinical trial","volume":"5","author":"Sun","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2022.02.036_b0060","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/annonc\/mdu567","article-title":"Randomized phase III trial of prophylactic cranial irradiation versus observation in patients with fully resected stage IIIA-N2 nonsmall-cell lung cancer and high risk of cerebral metastases after adjuvant chemotherapy","volume":"26","author":"Li","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2022.02.036_b0065","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1200\/JCO.2017.77.5817","article-title":"Prophylactic cranial irradiation versus observation in radically treated stage III non-small-cell lung cancer: a randomized phase III NVALT-11\/DLCRG-02 study","volume":"36","author":"De Ruysscher","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2022.02.036_b0070","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ejca.2019.04.017","article-title":"Screening for brain metastases in patients with stage III non-small-cell lung cancer, magnetic resonance imaging or computed tomography? A prospective study","volume":"115","author":"Schoenmaekers","year":"2019","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2022.02.036_b0075","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2165\/11586130-000000000-00000","article-title":"Standardizing the inclusion of indirect medical costs in economic evaluations","volume":"29","author":"van Baal","year":"2011","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.radonc.2022.02.036_b0080","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0197-2456(89)90005-6","article-title":"Measurement of health status. Ascertaining the minimal clinically important difference","volume":"10","author":"Jaeschke","year":"1989","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.radonc.2022.02.036_b0085","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jtho.2020.12.015","article-title":"Four-year survival with durvalumab after chemoradiotherapy in stage III NSCLC-an update from the PACIFIC trial","volume":"16","author":"Faivre-Finn","year":"2021","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2022.02.036_b0090","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/jama.1981.03310300023013","article-title":"Cranial irradiation in cancer of the lung of all cell types","volume":"245","author":"Cox","year":"1981","journal-title":"JAMA"},{"key":"10.1016\/j.radonc.2022.02.036_b0095","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF00253278","article-title":"Role of elective brain irradiation during combined chemoradiotherapy for limited disease non-small cell lung cancer","volume":"2","author":"Umsawasdi","year":"1984","journal-title":"J Neurooncol"},{"key":"10.1016\/j.radonc.2022.02.036_b0100","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/0360-3016(91)90681-S","article-title":"Prophylactic cranial irradiation for lung cancer patients at high risk for development of cerebral metastasis: Results of a prospective randomized trial conducted by the Radiation Therapy Oncology Group","volume":"21","author":"Russell","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.02.036_b0105","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0360-3016(90)90693-E","article-title":"Chest irradiation vs. chest irradiation plus chemotherapy with or without prophylactic brain radiotherapy in localized nonsmall lung cancer: a Southwest Oncology Group Study","volume":"19","author":"Mira","year":"1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.02.036_b0110","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1200\/JCO.2010.29.1609","article-title":"Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: Primary analysis of Radiation Therapy Oncology Group study RTOG 0214","volume":"29","author":"Gore","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2022.02.036_b0115","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1158\/0008-5472.CAN-12-0210","article-title":"Radiotherapy increases the permissiveness of established mammary tumors to rejection by immunomodulatory antibodies","volume":"72","author":"Verbrugge","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.radonc.2022.02.036_b0120","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature14292","article-title":"Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer","volume":"520","author":"Twyman-Saint Victor","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.radonc.2022.02.036_b0125","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.ijrobp.2003.09.012","article-title":"Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated","volume":"58","author":"Demaria","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.02.036_b0130","doi-asserted-by":"crossref","first-page":"5514","DOI":"10.1158\/1078-0432.CCR-16-1673","article-title":"Fractionated radiation therapy stimulates antitumor immunity mediated by both resident and infiltrating polyclonal T-cell populations when combined with PD-1 blockade","volume":"23","author":"Dovedi","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2022.02.036_b0135","doi-asserted-by":"crossref","first-page":"1832760","DOI":"10.1080\/2162402X.2020.1832760","article-title":"Immunotherapy as sensitizer for local radiotherapy","volume":"9","author":"Vanneste","year":"2020","journal-title":"Oncoimmunology"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814022001220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814022001220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:22:26Z","timestamp":1759123346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814022001220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":27,"alternative-id":["S0167814022001220"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2022.02.036","relation":{},"ISSN":["0167-8140"],"issn-type":[{"type":"print","value":"0167-8140"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-effectiveness of prophylactic cranial irradiation in stage III non-small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2022.02.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}